Abstract
Background and Aim: HBV infection is a global problem with nearly 350 million chronic carriers and over 50% of these carriers are believed to have acquired their infection vertically from their mothers, i.e. through mother - to - child transmission (MTCT). We studied a) to prevent MTCT of HBV by administrating antiviral drugs, as per indication to Hepatitis B positive pregnant mothers and mandatory HBV Vaccine and Hepatitis B immunoglobulin (HBIG) to newborn b) to evaluate vertical transmission to neonate
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have